AdvisorShares MSOS 2X Daily ETF

MSOX

Market cap $51.9M

Restatement Reflects Correction of Income Accrual Accounting for Total Return Swaps BETHESDA, Md., March 6, 2026 /PRNewswire/ -- AdvisorShares announced that the previously disclosed net asset value (NAV) per share of the AdvisorShares MSOS Daily Leveraged ETF (NYSE Arca: MSOX) has been restated due to the Fund Administrator not correctly accounting for income accruals for some of the total return swaps held from December 22, 2025, through February 2, 2026.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Cannabis, space, nat gas & auto led last week's leveraged ETF winners. MSOX, RKLX, KOLD, VOYX and CVNX posted outsized gains despite tech weakness.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

The S&P 500 capped its fourth straight monthly gain in August (per Yahoo Finance), while leveraged ETFs tied to cannabis, Reddit, gold miners and more soared. These winning ETFs are MSOX, RDTL, SMCZ, GDXU and APPX.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Cannabis ETF spent the first half of the year in the performance doldrums. But they have rallied of late on news that the Trump administration is open to reclassifying marijuana as a less dangerous drug.